File for regulatory approval of Trodelvy in Europe
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 14 Sep 2020
- Due
- 30 Jun 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Immunomedics is also on track to file for regulatory approval in Europe in the first half of 2021.”
What we found
Evidence strength A What the grades mean
Gilead's 2022 10-K filing confirms that Trodelvy received full regulatory approval in Europe in 2021, implying the filing commitment was met within the first half of 2021.
-
A Gilead Sciences Inc. 10-K filed 2022-02-23
“2021 revenues include continued uptake of Trodelvy following the full regulatory approval for metastatic TNBC in the United States and Europe” ✓ confirmed on the page
Market reaction: the shares moved -1.7% against the S&P 500 over the three sessions around the disclosure (22 Feb 2022 to 25 Feb 2022). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Regulatory other
- Indicative materiality
- Medium rules
- Action
- File
- Deliverable
- Regulatory approval filing
- Where
- Europe
- Language
- Firm (“will”, “on track to”)
- In the company’s control
- High
- Specificity
- High
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “no_evidence”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the recorded outcome.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Gilead Sciences Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2020-GILD-003182 · Corrections policy